Viewing StudyNCT01582243



Ignite Creation Date: 2024-05-06 @ 12:28 AM
Last Modification Date: 2024-10-26 @ 10:50 AM
Study NCT ID: NCT01582243
Status: COMPLETED
Last Update Posted: 2016-11-03
First Post: 2012-04-18

Brief Title: Safety and Efficacy of Vildagliptin Plus Metformin SPC Treatment in Type 2 Diabetes Mellitus Patients
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
vildagliptin View
Diabetes Mellitus type 2 View